Grizzly Research is short GeneDx (WGS), saying insiders attest that the company is “actively committing widespread fraud.” In a recently ...
Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra-rare genetic disorders ...
EST GeneDx (WGS) down 3% after Grizzly Research publishes short report, alleging fraudMaximize Your Portfolio with Data Driven ...
Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX (NASDAQ:WGS).
These contributions, added to GeneDx’s years of dedicated research efforts, influenced the broadening of phenotypes, the discovery of new disease mechanisms and new modes of inheritance ...
According to U.S.-based Grizzly Research LLC, many of the company’s European solar projects appear not to exist. Renesola has said it will review the report and address the key inaccuracies with ...
--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering ... where he successfully transformed the company from a research-stage start-up into a commercial operation. Bryan has also held ...